Literature DB >> 27574031

Development and evaluation of iManage: A self-management app co-designed by adolescents with sickle cell disease.

Lori E Crosby1,2,3, Russell E Ware2,4, Alana Goldstein5, Ashley Walton1,6, Naomi E Joffe1,2, Craig Vogel7, Maria T Britto2,8,3.   

Abstract

BACKGROUND: Adolescents and young adults (AYAs) with sickle cell disease (SCD) are a vulnerable population with high risk of morbidity that could be decreased with effective self-management. Previous research suggests that mobile applications (apps) may facilitate AYA engagement in health-promoting behaviors. The objectives of this study were: (i) describe Internet access and use in AYA with SCD; (ii) identify barriers for self-management in this population; (iii) collaborate with AYA to co-design a mobile app that would minimize barriers; and (iv) evaluate the feasibility and acceptability of the app. PROCEDURE: In phase 1, 46 AYAs with SCD 16-24 years of age completed a survey of Internet access and use. During phase 2, 19 AYAs with SCD (average age 20 ± 2.5 years) and eight healthcare providers participated in interviews to identify barriers and co-design sessions to develop the app. In phase 3, five AYAs with SCD completed app feasibility and usability testing.
RESULTS: AYAs with SCD had daily Internet access (69%) using their computers (84%) or mobile phones (70%). Participants went online for health information (71%) and preferred Web sites with interactive/social features (83%). Barriers to self-management included failing to believe that their health would suffer, lack of tailored self-management support, lack of a mechanism to visualize self-management progress, and limited opportunities for peer interaction around self-management. The prototype app (iManage) was rated as highly feasible and beneficial.
CONCLUSIONS: A mobile app prototype co-designed by AYAs with SCD may be a useful tool for engaging them in self-management strategies designed to improve health.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  AYA; Internet access; patient engagement; pediatric hematology; smartphone

Mesh:

Year:  2016        PMID: 27574031      PMCID: PMC7354646          DOI: 10.1002/pbc.26177

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  23 in total

1.  Population estimates of sickle cell disease in the U.S.

Authors:  Kathryn L Hassell
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

2.  Pediatric self-management: a framework for research, practice, and policy.

Authors:  Avani C Modi; Ahna L Pai; Kevin A Hommel; Korey K Hood; Sandra Cortina; Marisa E Hilliard; Shanna M Guilfoyle; Wendy N Gray; Dennis Drotar
Journal:  Pediatrics       Date:  2012-01-04       Impact factor: 7.124

Review 3.  Self-efficacy, transition, and patient outcomes in the sickle cell disease population.

Authors:  Brittany L Molter; Kathleen Abrahamson
Journal:  Pain Manag Nurs       Date:  2014-07-19       Impact factor: 1.929

4.  Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes.

Authors:  Jessica Greene; Judith H Hibbard
Journal:  J Gen Intern Med       Date:  2012-05       Impact factor: 5.128

5.  Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia.

Authors:  Jeremie H Estepp; Bryan Winter; Margery Johnson; Matthew P Smeltzer; Scott C Howard; Jane S Hankins
Journal:  Pediatr Blood Cancer       Date:  2014-08-17       Impact factor: 3.167

6.  Definitions of the phenotypic manifestations of sickle cell disease.

Authors:  Samir K Ballas; Susan Lieff; Lennette J Benjamin; Carlton D Dampier; Matthew M Heeney; Carolyn Hoppe; Cage S Johnson; Zora R Rogers; Kim Smith-Whitley; Winfred C Wang; Marilyn J Telen
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

Review 7.  Hydroxyurea for children with sickle cell disease.

Authors:  Matthew M Heeney; Russell E Ware
Journal:  Pediatr Clin North Am       Date:  2008-04       Impact factor: 3.278

Review 8.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

Review 9.  Patient-centered care and adherence: definitions and applications to improve outcomes.

Authors:  Janice H Robinson; Lynn C Callister; Judith A Berry; Karen A Dearing
Journal:  J Am Acad Nurse Pract       Date:  2008-12

10.  Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease.

Authors:  Sherif M Badawy; Alexis A Thompson; Robert I Liem
Journal:  Pediatr Blood Cancer       Date:  2016-02-04       Impact factor: 3.167

View more
  38 in total

Review 1.  mHealth for pediatric chronic pain: state of the art and future directions.

Authors:  Patricia A Richardson; Lauren E Harrison; Lauren C Heathcote; Gillian Rush; Deborah Shear; Chitra Lalloo; Korey Hood; Rikard K Wicksell; Jennifer Stinson; Laura E Simons
Journal:  Expert Rev Neurother       Date:  2020-09-23       Impact factor: 4.618

2.  The Role of Patient-Physician Communication on the Use of Hydroxyurea in Adult Patients with Sickle Cell Disease.

Authors:  Sarah M Jabour; Sara Beachy; Shayna Coburn; Sophie Lanzkron; Michelle N Eakin
Journal:  J Racial Ethn Health Disparities       Date:  2019-08-13

3.  A program of transition to adult care for sickle cell disease.

Authors:  Anjelica C Saulsberry; Jerlym S Porter; Jane S Hankins
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia.

Authors:  Sherif M Badawy; Kerry Morrone; Alexis Thompson; Tonya M Palermo
Journal:  Cochrane Database Syst Rev       Date:  2019-06-28

5.  Improving self-management in adolescents with sickle cell disease.

Authors:  Lori E Crosby; Anna Hood; Katherine Kidwell; Cara Nwankwo; James Peugh; Heather Strong; Charles Quinn; Maria T Britto
Journal:  Pediatr Blood Cancer       Date:  2020-07-22       Impact factor: 3.167

6.  Acceptability and Feasibility of a Disease-specific Patient Portal in Adolescents With Sickle Cell Disease.

Authors:  Katherine M Kidwell; James Peugh; Emilie Westcott; Cara Nwankwo; Maria T Britto; Charles T Quinn; Lori E Crosby
Journal:  J Pediatr Hematol Oncol       Date:  2019-10       Impact factor: 1.289

7.  Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia.

Authors:  Sherif M Badawy; Kerry Morrone; Alexis Thompson; Tonya M Palermo
Journal:  Cochrane Database Syst Rev       Date:  2017-12-14

8.  Technology use and preferences to support clinical practice guideline awareness and adherence in individuals with sickle cell disease.

Authors:  Amol Utrankar; Tilicia L Mayo-Gamble; Whitney Allen; Laurie Novak; Adetola A Kassim; Kemberlee Bonnet; David Schlundt; Velma M Murry; Gretchen Purcell Jackson; Michael DeBaun; Robert M Cronin
Journal:  J Am Med Inform Assoc       Date:  2018-08-01       Impact factor: 4.497

Review 9.  A scoping review of transition interventions for young adults with sickle cell disease.

Authors:  Adrienne Viola; Jerlym Porter; Jelaina Shipman; Ellen Brooks; Cecilia Valrie
Journal:  Pediatr Blood Cancer       Date:  2021-06-05       Impact factor: 3.167

10.  Feasibility of Medical Student Mentors to Improve Transition in Sickle Cell Disease.

Authors:  Adrienne S Viola; Richard Drachtman; Amanda Kaveney; Ashwin Sridharan; Beth Savage; Cristine D Delnevo; Elliot J Coups; Jerlym S Porter; Katie A Devine
Journal:  J Pediatr Psychol       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.